Venous thromboembolism, a clinical entity which includes deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a common, lethal disease that affects both hospitalized and …

Pulmonary embolism and deep venous thrombosis are the two most important
manifestations of venous thrombo-embolism (VTE), which is the third most common life …

Purpose. The long-term consequences of recurrent venous thromboembolism (VTE) and
post-thrombotic syndrome, clinical profiles of traditional and novel antithrombotic agents …

Venous thromboembolism (VTE), comprised of pulmonary embolism (PE) and deep vein
thrombosis (DVT), is a disease entity with a significant morbidity and mortality …

Venous thromboembolism, including deep vein thrombosis and pulmonary embolism,
represents a significant source of morbidity and mortality in the United States and worldwide …

Abstract Treatment of acute deep vein thrombosis and pulmonary embolism-often
denominated together as venous thromboembolism (VTE)-consists of parenteral …

Deep vein thrombosis (DVT) and pulmonary embolism (PE) are two manifestations of the
same disorder, venous thromboembolism, and low-molecular weight heparin is the …

Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary
embolism, is a common condition associated with a significant clinical and economic …

Deep vein thrombosis (DVT) affects an estimated 500,000 to 2 million people in the United
States per year. Approximately 250,000 hospital admissions occur annually, with an …

This review describes recent evidence relevant to the treatment of deep vein thrombosis
(DVT) and pulmonary embolism (PE). Because venous thromboembolism (VTE) is a …